Impact of Pool Testing in Detection of Asymptomatic Patients with COVID-19
Author(s) -
David L. Smalley,
Patricia Cisarik,
J. Aaron Grantham,
William Cloud,
Robert Neil,
Paul D. DePriest
Publication year - 2020
Publication title -
laboratory medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.332
H-Index - 28
eISSN - 1943-7730
pISSN - 0007-5027
DOI - 10.1093/labmed/lmaa094
Subject(s) - asymptomatic , pooling , covid-19 , real time polymerase chain reaction , serial dilution , medicine , virology , reverse transcriptase , polymerase chain reaction , biology , pathology , gene , genetics , computer science , disease , alternative medicine , artificial intelligence , infectious disease (medical specialty)
Objective During the current pandemic, COVID-19 has been detected in patients using real-time reverse transcriptase-polymerase chain reaction (RT-PCR) that confirms the presence of SARS-CoV-2 RNA. The demand for increased testing, particularly for asymptomatic individuals required alternative approaches to single-patient RT-PCR testing, such as pooling. Methods This study explored the impact of dilution on the detectability of SARS-CoV-2 in asymptomatic patients using RT-PCR and demonstrated that pooling can be effective in low prevalence populations. Results The RT-PCR results for the 3:1, 5:1, and 7:1 aliquot samples showed little differences in CT values, confirming detection capability at these dilutions. Conclusion Based on the results of the present study, a pooled approach with up to 5:1 sample aliquots and using the current RT-PCR methodology likely will detect SARS CoV2 RNA among asymptomatic patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom